Picture of Nexstim Oyj logo

NXTMH — Nexstim Oyj News Story

0.000.00%
fi flag iconLast trade - 00:00
HealthcareSpeculativeSmall CapNeutral

Brief: Nexstim H2 Operating Loss Narrows To EUR 0.5 Mln

Feb 28 (Reuters) - Nexstim Oyj  NXTMH.HE :
    * H2 REVENUES EUR 3.4 MILLION VERSUS EUR 2.5 MILLION YEAR
AGO
    * H2 OPERATING RESULT WAS EUR -0.5 MILLION (-1.5). OPERATING
LOSS
DECREASED BY 63.3%.
    * H2 THIS WAS FIRST PROFIT-MAKING REVIEW PERIOD IN COMPANY'S
HISTORY. RESULT FOR REVIEW PERIOD WAS EUR 0.1 MILLION (-3.0).
    * NEXSTIM AGREED ON A STRATEGIC INVESTMENT IN SERVICE
COMPANY OF A
CALIFORNIAN CLINIC (PNC MANAGEMENT, LLC), WHICH PROVIDES
TREATMENT FOR PATIENTS WITH DEPRESSION. VALUE OF INVESTMENT IS
AROUND EUR 0.5 MILLION
    * OUTLOOK: BASED ON BUSINESS FORECASTS, COMPANY EXPECTS ITS
REVENUE TO CONTINUE TO GROW DURING YEAR 2022, AND OPERATING
RESULT FOR FINANCIAL YEAR TO BE POSITIVE.

Source text for Eikon:  ID:nGNE2tQM7q 
Further company coverage:  NXTMH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

Recent news on Nexstim Oyj

See all news